Abstract:Placental accumulation of Plasmodium falciparum infected erythrocytes results in maternal anemia, low birth weight, and pregnancy loss. The parasite protein VAR2CSA facilitates the accumulation of infected erythrocytes in the placenta through interaction with the host receptor chondroitin sulfate A (CSA). Antibodies that prevent the VAR2CSA-CSA interaction correlate with protection from placental malaria, and VAR2CSA is a high-priority placental malaria vaccine antigen. Here, structure-guided design leveraging the full-length structures of VAR2CSA produced a stable immunogen that retains the critical conserved functional elements of VAR2CSA. The design expressed with a six-fold greater yield than the full-length protein and elicited antibodies that prevent adhesion of infected erythrocytes to CSA. The reduced size and adaptability of the designed immunogen enable efficient production of multiple variants of VAR2CSA for use in a cocktail vaccination strategy to increase the breadth of protection. These designs form strong foundations for the development of potent broadly protective placental malaria vaccines. Malaria remains a major cause of death globally despite considerable dedication to eradication. Plasmodium falciparum is the most lethal malaria parasite that infects human. One reason for the parasite's deadly impact lies in the expression of the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) protein family. These proteins adhere to host receptors leading to parasite accumulation in various tissues and organs. VAR2CSA is a PfEMP1 protein that binds to a host receptor in the placenta causing severe outcomes for pregnant women and their unborn children including maternal anemia, low birth weight, still birth, and loss of pregnancy. The development of a vaccine to combat these devastating outcomes has long been anticipated, but the intricate and diverse nature of VAR2CSA has posed significant hurdles. Here, we adopted structure-guided principles to design a next-generation VAR2CSA vaccine candidate, HPISVpmv1, that is stable, has high production yields, and consists of the entire functional domains of VAR2CSA. Preclinical studies showed that HPISVpmv1 is immunogenic and effective, and the adoption of a cocktail immunization strategy produced antibodies that worked against multiple strains. This work provides new insights into vaccine development for malaria and other highly variable human pathogens.

Global Genetic Diversity and Evolution of Var Genes Associated with Placental and Severe Childhood Malaria

Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA.

The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes

Exploring Plasmodium falciparum Var Gene Expression to Assess Host Selection Pressure on Parasites During Infancy

Plasmodium falciparum var gene expression is modified by host immunity

Plasmodium Falciparum: Isolation of Large Numbers of Parasite Clones from Infected Blood Samples.

Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding

Analysis of Var Genes Cloned from a Plasmodium Falciparum Isolate in China

A coordinated transcriptional switching network mediates antigenic variation of human malaria parasites

Resistance to malaria through structural variation of red blood cell invasion receptors

Cryo-EM Reveals the Conformational Epitope of Human Monoclonal Antibody PAM1.4 Broadly Reacting with Polymorphic Malarial Protein VAR2CSA.

Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome

Structure-guided design of VAR2CSA-based immunogens and a cocktail strategy for a placental malaria vaccine

Genotyping var Gene DBL1α Domain of Severe and Non-severe Plasmodium falciparum Patients

An Invariant Protein That Colocalizes With VAR2CSA on Plasmodium falciparum-Infected Red Cells Binds to Chondroitin Sulfate A

Plasmodium falciparum var Gene Expression Homogeneity as a Marker of the Host-Parasite Relationship under Different Levels of Naturally Acquired Immunity to Malaria

From In Vivo to In Vitro: Dynamic Analysis of Plasmodium falciparum var Gene Expression Patterns of Patient Isolates during Adaptation to Culture

Epigenetic regulation of Plasmodium falciparum clonally variant gene expression during development in Anopheles gambiae

A novel computational pipeline for var gene expression augments the discovery of changes in the Plasmodium falciparum transcriptome during transition from in vivo to short-term in vitro culture

Role for gene conversion in the evolution of cell-surface antigens of the malaria parasite Plasmodium falciparum

Infections with Plasmodium falciparum during pregnancy affect VAR2CSA DBL-5 domain-specific T cell cytokine responses